Zai Lab (ZLAB) Amortization of Deferred Charges (2020 - 2026)
Zai Lab's (ZLAB) quarterly Amortization of Deferred Charges came in at -$1.4 million in Q1 2026, down 4.66% year-on-year from -$1.5 million in Q1 2025, and down 1647.78% quarter-over-quarter from $90000.0 in Q3 2025.
Zai Lab (ZLAB) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Amortization of Deferred Charges across 7 years of filings, most recently posting -$1.4 million for Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at -$1.4 million, down 4.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $132000.0 (up 102.38% YoY), and the FY2025 annual result was $194000.0, up 105.51% from the prior year.
- Amortization of Deferred Charges came in at -$1.4 million for Q1 2026 at Zai Lab, down from $90000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $1.4 million in Q2 2025 to a low of -$3.4 million in Q4 2023.
- The 5-year median for Amortization of Deferred Charges is -$678000.0 (2022), against an average of -$713600.0.
- Across the five-year window, Amortization of Deferred Charges slumped 807.69% in 2022 and soared 220.27% in 2024, its largest moves.
- Zai Lab's Amortization of Deferred Charges stood at -$561000.0 in 2022, then sank by 503.03% to -$3.4 million in 2023, then soared by 70.38% to -$1.0 million in 2024, then surged by 108.98% to $90000.0 in 2025, then slumped by 1647.78% to -$1.4 million in 2026.
- The last three Amortization of Deferred Charges figures came in at -$1.4 million (Q1 2026), $90000.0 (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39 Mn |
| Mar 31, 2026 | -1.39 Mn |
| Sep 30, 2025 | 90,000.00 |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | -1.33 Mn |
| Mar 31, 2025 | -1.33 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -839,000.00 |
| Sep 30, 2024 | -839,000.00 |
| Jun 30, 2024 | -2.38 Mn |
| Jun 30, 2024 | -2.38 Mn |
| Mar 31, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | -3.38 Mn |
| Dec 31, 2023 | -3.38 Mn |
| Jun 30, 2023 | 582,000.00 |
| Jun 30, 2023 | 582,000.00 |